Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Ingresos
1,062,416
1,036,171
921,863
820,209
703,303
613,842
Crecimiento de los Ingresos (YoY)
8%
12%
12%
17%
15%
-2%
Costo de los ingresos
486,304
475,501
442,688
402,839
333,962
287,219
Utilidad bruta
576,112
560,670
479,175
417,370
369,341
326,623
Venta, General y Administración
386,772
279,533
250,917
214,921
178,788
160,375
Investigación y Desarrollo
--
74,224
69,060
61,583
51,837
49,096
Gastos de Operación
405,177
379,494
342,919
297,579
252,677
229,180
Otras Ingresos (Gastos) No Operativos
-2
105
887
985
227
844
Ingreso antes de impuestos
170,646
154,574
140,829
116,137
114,501
97,060
Gasto por Impuesto a la Renta
39,975
37,595
34,455
26,811
25,687
19,859
Ingreso Neto
130,671
116,978
106,374
89,325
88,813
77,268
Crecimiento de la Utilidad Neta
9%
10%
19%
1%
15%
-9%
Acciones en Circulación (Diluidas)
1,475.03
1,480.54
1,488.4
1,501.87
1,513.32
1,513.52
Cambio de Acciones (YoY)
-1%
-1%
-1%
-1%
0%
100%
EPS (Diluido)
88.58
79.01
71.46
59.47
58.68
51.05
Crecimiento de EPS
10%
11%
20%
1%
15%
-55%
Flujo de efectivo libre
126,149
128,436
67,555
45,363
67,362
38,361
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
54.22%
54.1%
51.97%
50.88%
52.51%
53.2%
Margen de operación
16.08%
17.48%
14.78%
14.6%
16.58%
15.87%
Margen de beneficio
12.29%
11.28%
11.53%
10.89%
12.62%
12.58%
Margen de flujo de caja libre
11.87%
12.39%
7.32%
5.53%
9.57%
6.24%
EBITDA
257,383
266,625
213,001
190,029
175,546
151,375
Margen de EBITDA
24.22%
25.73%
23.1%
23.16%
24.96%
24.66%
D&A para EBITDA
86,448
85,449
76,745
70,238
58,882
53,932
EBIT
170,935
181,176
136,256
119,791
116,664
97,443
Margen de EBIT
16.08%
17.48%
14.78%
14.6%
16.58%
15.87%
Tasa de Impuesto Efectiva
23.42%
24.32%
24.46%
23.08%
22.43%
20.46%
Estadísticas clave
Cierre Anterior
$13.34
Precio de apertura
$13.26
Rango del día
$13.26 - $14.73
Rango de 52 semanas
$13.28 - $20.18
Volumen
10.5K
Volumen promedio
295.9K
EPS (TTM)
0.56
Rendimiento de dividendos
--
Cap. de mercado
$21.6B
¿Qué es Terumo Corp.?
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 30,689 full-time employees. The firm operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.